Stage III Non-small Cell Lung Cancer

Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

PALACE: Cemiplimab Trial According to ctDNA Levels

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC

Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia"

Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial

Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy